Risk-on Biotech Investors Should Buy Cassava Sciences

InvestorPlace - Stock Market News, Stock Advice & Trading Tips

SAVA stock is volatile but worthwhile after opinion shifts in its favor. Remember, it has a blockbuster Alzheimer's drug nearing launch.

The post Risk-on Biotech Investors Should Buy Cassava Sciences appeared first on InvestorPlace.

• Get in Now on Tiny $3 ‘Forever Battery’ Stock
• It doesn’t matter if you have $500 in savings or $5 million. Do this now.
• Stock Prodigy Who Found NIO at $2… Says Buy THIS
• Early Bitcoin Millionaire Reveals His Next Big Crypto Trade “On Air”